Pfizer sues Mylan over atorvastatin
This article was originally published in Scrip
Executive Summary
Ranbaxy is set to become the first company to sell a generic version of Lipitor (atorvastatin calcium) in the US, starting in November 2011. But litigation surrounding generic Lipitor continues, and Pfizer has just initiated a patent suit against Mylan Laboratories.